📈 Stocks
Astellas Pharma Stock Tumbles as Five-Year Plan Disappoints Investors
(4 days ago)
Astellas Pharma shares fell in Tokyo after the company’s five-year strategic plan disappointed investors with modest growth targets and pipeline uncertainty.